These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 34369137)

  • 1. Personalized immunotherapy in cancer precision medicine.
    Kiyotani K; Toyoshima Y; Nakamura Y
    Cancer Biol Med; 2021 Aug; 18(4):955-65. PubMed ID: 34369137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenomics in personalized cancer treatments.
    Kiyotani K; Toyoshima Y; Nakamura Y
    J Hum Genet; 2021 Sep; 66(9):901-907. PubMed ID: 34193979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunopharmacogenomics towards personalized cancer immunotherapy targeting neoantigens.
    Kiyotani K; Chan HT; Nakamura Y
    Cancer Sci; 2018 Mar; 109(3):542-549. PubMed ID: 29288513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cancer Vaccine Focused on Neoantigens].
    Shindo Y; Hazama S; Nagano H
    Gan To Kagaku Ryoho; 2019 Sep; 46(9):1367-1371. PubMed ID: 31530772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the undruggable: immunotherapy meets personalized oncology in the genomic era.
    Martin SD; Coukos G; Holt RA; Nelson BH
    Ann Oncol; 2015 Dec; 26(12):2367-74. PubMed ID: 26371284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer neoantigens as potential targets for immunotherapy.
    Ma W; Pham B; Li T
    Clin Exp Metastasis; 2022 Feb; 39(1):51-60. PubMed ID: 33950415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoantigen vaccine and neoantigen-specific cell adoptive transfer therapy in solid tumors: Challenges and future directions.
    Shen Y; Yu L; Xu X; Yu S; Yu Z
    Cancer Innov; 2022 Aug; 1(2):168-182. PubMed ID: 38090649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoantigens: promising targets for cancer therapy.
    Xie N; Shen G; Gao W; Huang Z; Huang C; Fu L
    Signal Transduct Target Ther; 2023 Jan; 8(1):9. PubMed ID: 36604431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New emerging targets in cancer immunotherapy: the role of neoantigens.
    De Mattos-Arruda L; Blanco-Heredia J; Aguilar-Gurrieri C; Carrillo J; Blanco J
    ESMO Open; 2020 Apr; 4(Suppl 3):e000684. PubMed ID: 32269031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer Neoantigens: Challenges and Future Directions for Prediction, Prioritization, and Validation.
    Borden ES; Buetow KH; Wilson MA; Hastings KT
    Front Oncol; 2022; 12():836821. PubMed ID: 35311072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in personalized cancer immunotherapy with immune checkpoint inhibitors, T cells and vaccines.
    Faghfuri E
    Per Med; 2024 Jan; 21(1):45-57. PubMed ID: 38088165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting neoantigens for cancer immunotherapy.
    Zhao X; Pan X; Wang Y; Zhang Y
    Biomark Res; 2021 Jul; 9(1):61. PubMed ID: 34321091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering neoantigen vaccines to improve cancer personalized immunotherapy.
    Liu Z; Lv J; Dang Q; Liu L; Weng S; Wang L; Zhou Z; Kong Y; Li H; Han Y; Han X
    Int J Biol Sci; 2022; 18(15):5607-5623. PubMed ID: 36263174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized Immuno-Oncology.
    Jain KK
    Med Princ Pract; 2021; 30(1):1-16. PubMed ID: 32841942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoantigens and their clinical applications in human gastrointestinal cancers.
    Eshkiki ZS; Agah S; Tabaeian SP; Sedaghat M; Dana F; Talebi A; Akbari A
    World J Surg Oncol; 2022 Sep; 20(1):321. PubMed ID: 36171610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of T Cell Receptors Targeting a Neoantigen Derived from Recurrently Mutated FGFR3.
    Tate T; Matsumoto S; Nemoto K; Leisegang M; Nagayama S; Obama K; Nakamura Y; Kiyotani K
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in personalized cancer immunotherapy.
    Kakimi K; Karasaki T; Matsushita H; Sugie T
    Breast Cancer; 2017 Jan; 24(1):16-24. PubMed ID: 27000871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapy.
    Richard G; Princiotta MF; Bridon D; Martin WD; Steinberg GD; De Groot AS
    Expert Rev Vaccines; 2022 Feb; 21(2):173-184. PubMed ID: 34882038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in personalized neoantigen vaccines for cancer immunotherapy.
    Sun C; Xu S
    Biosci Trends; 2020 Nov; 14(5):349-353. PubMed ID: 32908077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Neoantigens in Cancer Immunotherapy.
    Zhu Y; Liu J
    Front Oncol; 2021; 11():682325. PubMed ID: 34513673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.